Similarly, in CAR T cells, CD28 was linked to robust short-term tumor lysis, heightened sensitivity, and reactivity to modestly expressed, including on-target off-tumor, antigens (20, 23, 51, 94). The gene discussed is CD28; the disease is neoplasm.